Ferritin heavy chain participated in ameliorating 3-nitropropionic acid-induced oxidative stress and apoptosis of goose follicular granulosa cells. 2023

Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, PR China; Key Laboratory of Livestock and Poultry Multi-omics, Ministry of Agriculture and Rural Affairs, Sichuan Agricultural University, Chengdu, PR China; Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province, Sichuan Agricultural University, Chengdu, PR China.

Oxidative stress is the major culprits responsible for ovarian dysfunction by damaging granulosa cells (GCs). Ferritin heavy chain (FHC) may participate in the regulation of ovarian function by mediating GCs apoptosis. However, the specific regulatory function of FHC in follicular GCs remains unclear. Here, 3-nitropropionic acid (3-NPA) was utilized to establish an oxidative stress model of follicular GCs of Sichuan white geese. To explore the regulatory effects of FHC on oxidative stress and apoptosis of primary GCs in geese by interfering or overexpressing FHC gene. After transfection of siRNA-FHC to GCs for 60 h, the expressions of FHC gene and protein decreased significantly (P < 0.05). After FHC overexpression for 72 h, the expressions of FHC mRNA and protein upregulated considerably (P < 0.05). The activity of GCs was impaired after interfering with FHC and 3-NPA coincubated (P < 0.05). When overexpression of FHC combined with 3-NPA treatment, the activity of GCs was remarkably enhanced (P < 0.05). After interference FHC and 3-NPA treatment, NF-κB and NRF2 gene expression decreased (P < 0.05), the intracellular reactive oxygen species (ROS) level increased greatly (P < 0.05), BCL-2 expression reduced, BAX/BCL-2 ratio intensified (P < 0.05), the mitochondrial membrane potential decreased notably (P < 0.05), and the apoptosis rate of GCs aggravated (P < 0.05). While overexpression of FHC combined with 3-NPA treatment could promote BCL-2 protein expression and reduce BAX/BCL-2 ratio, indicating that FHC regulated the mitochondrial membrane potential and apoptosis of GCs by mediating the expression of BCL-2. Taken together, our research manifested that FHC alleviated the inhibitory effect of 3-NPA on the activity of GCs. FHC knockdown could suppress the expression of NRF2 and NF-κB genes, reduce BCL-2 expression and augment BAX/BCL-2 ratio, contributing to the accumulation of ROS and jeopardizing mitochondrial membrane potential, as well as exacerbating GCs apoptosis.

UI MeSH Term Description Entries
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D005260 Female Females
D005777 Geese Any of various large waterfowl in the order Anseriformes, especially those of the genera Anser (gray geese) and Branta (black geese). They are larger than ducks but smaller than swans, prefer FRESH WATER, and occur primarily in the northern hemisphere. Goose,Gooses
D006107 Granulosa Cells Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH). Cell, Granulosa,Cells, Granulosa,Granulosa Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001052 Apoferritins The protein components of ferritins. Apoferritins are shell-like structures containing nanocavities and ferroxidase activities. Apoferritin shells are composed of 24 subunits, heteropolymers in vertebrates and homopolymers in bacteria. In vertebrates, there are two types of subunits, light chain and heavy chain. The heavy chain contains the ferroxidase activity. Apoferritin,Ferritin H Subunit,Ferritin Heavy Chain,Ferritin L Subunit,Ferritin Light Chain,H Ferritin,H-Ferritin,L-Ferritin,Ferritin, H,H Subunit, Ferritin,Heavy Chain, Ferritin,L Ferritin,L Subunit, Ferritin,Light Chain, Ferritin
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D051028 bcl-2-Associated X Protein A member of the Bcl-2 protein family and homologous partner of C-BCL-2 PROTO-ONCOGENE PROTEIN. It regulates the release of CYTOCHROME C and APOPTOSIS INDUCING FACTOR from the MITOCHONDRIA. Several isoforms of BCL2-associated X protein occur due to ALTERNATIVE SPLICING of the mRNA for this protein. Bax Protein,Bax-alpha Protein,Bax-omega Protein,Bax-sigma Protein,Bax Apoptosis Regulator Protein,Bax-beta Protein,Bax-delta Protein,bcl2-Associated X Protein,bcl2-Associated X Protein Isoform alpha,bcl2-Associated X Protein Isoform beta,bcl2-Associated X Protein Isoform delta,bcl2-Associated X Protein Isoform omega,bcl2-Associated X Protein Isoform sigma,Bax alpha Protein,Bax beta Protein,Bax delta Protein,Bax omega Protein,Bax sigma Protein,Protein, bcl-2-Associated X,X Protein, bcl-2-Associated,bcl 2 Associated X Protein,bcl2 Associated X Protein,bcl2 Associated X Protein Isoform alpha,bcl2 Associated X Protein Isoform beta,bcl2 Associated X Protein Isoform delta,bcl2 Associated X Protein Isoform omega,bcl2 Associated X Protein Isoform sigma

Related Publications

Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
March 2024, British poultry science,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
October 2018, Bioscience reports,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
February 2024, International journal of molecular sciences,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
March 2004, Journal of neurochemistry,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
September 2007, Carcinogenesis,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
March 2004, European journal of pharmacology,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
November 2004, European journal of pharmacology,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
January 2016, PloS one,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
August 1996, Neurochemistry international,
Dongmei Jiang, and Chunyang Niu, and Guilin Mo, and Xin Wang, and Qian Sun, and Xiaoguang An, and Chengweng Ji, and Weikang Ling, and Liang Li, and Hua Zhao, and Chunchun Han, and Hehe Liu, and Jiwei Hu, and Bo Kang
June 2005, Pharmacology,
Copied contents to your clipboard!